Cytrellis Biosystems

About:

Cytrellis is a medical technology company that develops aesthetic devices.

Top Investors: Sands Capital Ventures, ARCH Venture Partners, PFM Health Sciences, Partner Fund Management, D1 Capital Partners

Description:

Cytrellis Biosystems is a clinical stage medical technology company that designs and develops medical device for dermatology, scar reduction, and aesthetic medicine. Its devices are designed to remove sagging skin associated with aging without surgery or scarring, providing aesthetic practitioners an unprecedented ability to improve age related changes in skin. Cytrellis Biosystems was founded in 2011 and is based in Boston, Massachusetts.

Total Funding Amount:

$86.1M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Boston, Massachusetts, United States

Founded Date:

2012-01-01

Contact Email:

info(AT)cytrellis.com

Founders:

Doug Levinson

Number of Employees:

11-50

Last Funding Date:

2021-01-04

IPO Status:

Private

Industries: